NASHVILLE, Tenn. (AP) _ Harrow Health, Inc. (HROW) on Thursday reported a fourth-quarter loss of $7.4 million, after reporting a profit in the same period a year earlier.On a per-share basis, the Nashville, Tennessee-based company said it had a loss of 27 cents. Losses, adjusted for investment costs and research and development costs, were 1 cent per share.The pharmaceutical and drug compounding company posted revenue of $20.2 million in the period.For the year, the company reported that its loss widened to $18 million, or 69 cents per share. Revenue was reported as $72.5 million._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HROW at https://www.zacks.com/ap/HROW